SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+48.44%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$388M
AUM Growth
+$388M
(+20%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
6.52%
Top 10 Holdings %
Top 10 Hldgs %
82.04%
Holding
61
New
5
Increased
9
Reduced
7
Closed
18
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$85.3M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$29.3M |
| 3 |
Cigna
CI
|
$17.5M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$12.2M |
| 5 |
Protagonist Therapeutics
PTGX
|
$4.86M |
Top Sells
| 1 |
GE HealthCare
GEHC
|
$16.5M |
| 2 |
BCYC
Bicycle Therapeutics
BCYC
|
$16M |
| 3 |
Pfizer
PFE
|
$14.9M |
| 4 |
Organon & Co
OGN
|
$13.3M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$12.6M |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $85.3M | 19.42% | +1,451,925 | New | +$85.3M |
|
|
GRCL
2
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $50.2M | 11.43% | 5,001,580 +2,920,364 | +140% | +$29.3M |
|
3
Labcorp
LH
$23.1B
| $37.5M | 8.55% | 165,123 -3,686 | -2% | -$838K |
|
|
4
Cigna
CI
$80.3B
| $34.9M | 7.95% | 116,553 +58,327 | +100% | +$17.5M |
|
5
Globus Medical
GMED
$8.27B
| $28.4M | 6.46% | 532,089 +15,108 | +3% | +$805K |
|
6
GSK
GSK
$79.9B
| $21.2M | 4.82% | 571,391 +62,391 | +12% | +$2.31M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $19.1M | 4.35% | 644,366 +411,615 | +177% | +$12.2M |
|
8
United Therapeutics
UTHR
$13.8B
| $17.6M | 4.01% | 80,050 -1,556 | -2% | -$342K |
|
9
Embecta
EMBC
$847M
| $13.9M | 3.17% | 736,008 +167,714 | +30% | +$3.17M |
|
|
10
Protagonist Therapeutics
PTGX
$3.67B
| $10.5M | 2.4% | 460,044 +211,917 | +85% | +$4.86M |
|
11
Teleflex
TFX
$5.59B
| $9.11M | 2.07% | 36,527 -27,964 | -43% | -$6.97M |
|
12
Zimmer Biomet
ZBH
$21B
| $8.8M | 2% | 72,300 -1,100 | -1% | -$134K |
|
13
Healthcare Services Group
HCSG
$1.13B
| $8.4M | 1.91% | 810,307 | – | – |
|
14
ARS Pharmaceuticals
SPRY
$1.15B
| $6.06M | 1.38% | 1,105,911 | – | – |
|
15
BridgeBio Pharma
BBIO
$9.89B
| $5.32M | 1.21% | 131,753 -91,194 | -41% | -$3.68M |
|
16
Ocular Therapeutix
OCUL
$2.12B
| $4.33M | 0.99% | +971,446 | New | +$4.33M |
|
|
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.87M | 0.88% | 288,466 | – | – |
|
|
HARP
18
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.39M | 0.77% | 297,936 +129,919 | +77% | +$1.48M |
|
19
X4 Pharmaceuticals
XFOR
$84.2M
| $3.01M | 0.69% | 3,588,427 +989,424 | +38% | +$830K |
|
|
FUSN
20
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.36M | 0.54% | 246,036 | – | – |
|
|
CMPS
21
Compass Pathways
CMPS
$424M
| $2.2M | 0.5% | +251,532 | New | +$2.2M |
|
22
Arcutis Biotherapeutics
ARQT
$1.86B
| $2.05M | 0.47% | 635,969 | – | – |
|
|
THRD
23
DELISTED
Third Harmonic Bio
THRD
| $1.79M | 0.41% | +163,363 | New | +$1.79M |
|
24
Prelude Therapeutics
PRLD
$68.5M
| $1.37M | 0.31% | 320,394 -29,606 | -8% | -$126K |
|
25
Aprea Therapeutics
APRE
$9.09M
| $1.32M | 0.3% | 280,000 | – | – |
|